Journal article

FIRST‐LINE IBRUTINIB VENETOCLAX TREATMENT FOR MANTLE CELL LYMPHOMA IN OLDER PATIENTS OR THOSE WITH TP53 MUTATION: A NEW OPEN‐LABEL ARM OF THE PHASE 3 PCYC‐1143 SYMPATICO STUDY

W Jurczak, C Tam, K Eckert, J Lin, JK Neuenburg, ML Wang

Hematological Oncology | Wiley | Published : 2021

DOI: 10.1002/hon.172_2880

University of Melbourne Researchers

Keywords

32 Biomedical and Clinical Sciences
Cancer
3 Good Health and Well Being
Rare Diseases
Hematology
Clinical Research
Aging
3211 Oncology and Carcinogenesis
Lymphatic Research
6.2 Cellular and Gene Therapies
3201 Cardiovascular Medicine and Haematology
Orphan Drug
Lymphoma